Showing results (111-120 of 527) with videos related to
Sort By:
Pageof 53
Journal of Neuroscience Research|January 1, 1987
Is the muscarinic receptor that mediates potentiation of dopamine release negatively coupled to the cyclic GMP system?M Marchi, P Paudice, A Gemignani, et al.Neuroscience Letters|January 16, 1989
Muscarinic inhibition of endogenous glutamate release from rat hippocampus synaptosomesM Marchi, P Bocchieri, L Garbarino, et al.Neurochemical Research|September 1, 1988
The activation of phosphatidylinositol turnover is not directly involved in the modulation of neurotransmitter release mediated by presynaptic muscarinic receptorsM Marchi, G Fontana, P Paudice, et al.Neuroradiology|March 1, 1997
Haemangioma of the zygoma: case reportV Pinna, L Clauser, M Marchi, et al.Minerva Gastroenterologica E Dietologica|March 1, 1994
[Azithromycin-omeprazole. Treatment for the eradication of Helicobacter pylori]M Marchi, R Vacondio, A Bagnulo, et al.Minerva Anestesiologica|January 1, 1990
[Autocontrol of muscle relaxation with vecuronium]C Sibilla, R Zatelli, M Marchi, et al.European Journal of Pharmacology|October 7, 1986
Dicyclomine- and pirenzepine-sensitive muscarinic receptors mediate inhibition of [3H]serotonin release in different rat brain areasM Marchi, P Paudice, M Bella, et al.Neurochemical Research|May 1, 1983
Calcium-dependent [3H]acetylcholine release and muscarinic autoreceptors in rat cortical synaptosomes during developmentM Marchi, A Caviglia, P Paudice, et al.Fundamental & Clinical Pharmacology|January 1, 1987
[3]Pirenzepine binding in rat corpus striatum decreases after hemitransection of the nigro-striatal pathwayA Pittaluga, P Versace, M Marchi, et al.American Journal of Ophthalmology|February 15, 1986
Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparationsT Hida, D Chandler, J E Arena, et al.Pageof 53